In mid-November 2016 the government issued directives to review the pricing and reimbursement system and the national financing system for medicinal products. The government declared that the existing system is complex and complicated and must be improved in order to operate a modern healthcare system.
The review seeks to find a clear division of financing responsibilities between the national government and local county councils. It also seeks to establish foreseeable processes for stakeholders as regards pricing.
The report from the review will be presented to the government on 1 December 2018.
Jonas Löfgren and Annie Kabala comment the review in the latest newsletter from ILO.